Market Herald logo

Subscribe

Be the first with the news that moves the market
  • AMP German Cannabis (CSE:XCX) subsidiary, AMP Germany, has received an AMRadV irradiation permit from BfArM
  • Now, the company has all necessary licences to import, store and distribute its irradiated EU-GMP certified medical cannabis flower
  • AMP will store the product at its licensed narcotic storage facility, and distribute it to the company’s pharmaceutical distributors
  • To date, all medical cannabis imported into Germany has been irradiated 
  • AMP’s share price was trading for C$0.29 per share at Thursday’s market close

AMP German Cannabis (CSE:XCX) subsidiary, AMP Alternative Medical Products GmbH, has received an AMRadV irradiation permit from BfArM.

The Federal Institute for Drugs and Medical Devices (BfArM), granted the AMRadV License to the subsidiary, AMP Germany. The permit specifically allows for the distribution of medical cannabis flowers which have undergone ionising radiation treatment.

The company now has all necessary licences to import, store and distribute its irradiated EU-GMP certified medical cannabis flower.

AMP will store the product at its licensed narcotic storage facility and distribute it to pharmaceutical distributors. 

The European Pharmacopoeia defines very specific quality standards for pharmaceutical goods across the continent. EU-GMP medical cannabis imported into Germany should comply with acceptable microbial levels. If they do not, they must undergo microbial sterilisation before becoming available for sale in Germany’s medical cannabis program. 

To date, all medical cannabis that has been imported into Germany has been irradiated, and requires an AMRadV License. 

AMP’s President, Dr Stefan Feuerstein, said that the AMRadV Licence grant is an important last step for AMP’s import capabilities. The company will now be able to import from Europe and elsewhere. 

“AMP will now complete the EU-GMP certification audit of its supply chain, and start the process with the Netherlands Ministry of Health. The Ministry supplies and organises the export of medical cannabis flowers from the Netherlands.

“AMP plans to start imports from the Netherlands in May, and Canada during the latter part of 2020,” he revealed.

AMP’s share price was trading for C$0.29 per share at Thursday’s market close.

More From The Market Herald

" BioHarvest (CSE:BHSC) predicts 2022 revenue to grow up to 3.5 times

BioHarvest Sciences Inc. (BHSC) expects strong revenue growth to continue in 2022 due to a successful over-delivery of projected revenue targets from last year.

" Icanic Brands (CSE:ICAN) agrees to acquire cannabis extraction company

Icanic Brands Company (ICAN) has signed a definitive agreement to acquire 100 per cent of LEEF Holdings Inc.
Tilray - Denise Faltischek, Head of International and Chief Strategy Officer.

" Tilray (TSX:TLRY) expands Australian medical cannabis offering

Tilray (TLRY) has expanded its medical cannabis product suite in Australia.

" Craftport Cannabis (CSE:CFT) announces $3M private placement

Craftport Cannabis (CFT) has announced a non-brokered private placement for gross proceeds of $3 million.